Sanofi India Limited - Company Profile

Q: Who are the current directors of Sanofi India Limited?

The current directors of Sanofi India Limited are Deepak Arora, Renee Viswonath Amonkar, Vaibhav Vinayak Karandikar, Rodolfo Hrosz, Rachid Ayari, Usha Thorat, Eric Yves Mansion, Rahul Bhatnagar, Aditya Narayan, Mahadev Keshav Gawade.

It is a pharma public limited company based in Mumbai, Maharashtra, India, established in 1956.

1956 Mumbai, Maharashtra, India Active

Last Updated: January 07, 2026

Access Report

About Sanofi India Limited

Sanofi India Limited, a active public limited company, was established on 02 May 1956 in Mumbai, Maharashtra, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: L24239MH1956PLC009794. Registered under ROC Roc Mumbai. it is listed on BSE: 500674 and NSE: SANOFI. It has an authorized capital of ₹23.50 Cr and a paid-up capital of ₹23.03 Cr.

Formerly known as Hoechst Fedco Pharma P Ltd, Hoechst Fedco Pharma Ltd. It upholds a compliant status. In 2023, it reported revenue of ₹2,916.40 Cr and a net worth of ₹1,015.53 Cr. Employing 2,191 professional, Its leadership includes Deepak Arora (Managing Director), Renee Viswonath Amonkar (Whole-Time Director), Vaibhav Vinayak Karandikar (Director). Past directors included Deepak Arora, Vijay Mallya, Rangaswamy Rathakrishnan Iyer. It holds ₹170.72 Cr open charges and ₹40.81 Cr settled loans. Its latest AGM occurred on 15 May 2025, with the balance sheet filed on 31 December 2024. It is based at Sanofi House, Cts No.117-B, L&T Business Park Saki Vihar Road, Powai, Mumbai, Maharashtra, 400072.

Company Details

CIN/LLPIN
L24239MH1956PLC009794
Registration Number
009794
Incorporation Date
02 May 1956
Authorized Capital
₹23.50 Cr
Paid-Up Capital
₹23.03 Cr
ROC Code
Roc Mumbai
Listing Status
Listed (BSE: 500674, NSE: SANOFI)
Company Status
Active

Key Metrics

Authorised Capital ₹ 23.50 Cr as on 07-01-2026
Paid Up Capital ₹ 23.03 Cr as on 07-01-2026
Company Age 70 Year, 2 Months
Last Filing with ROC 31 Dec 2024
Open Charges ₹ 170.72 Cr as on 07-01-2026
Satisfied Charges ₹ 40.81 Cr as on 07-01-2026
Revenue Growth **** 2.63% (FY 2023)
Profit Growth **** -2.80% (FY 2023)
Ebitda **** 14.14% (FY 2023)
Net Worth -20.40% (FY 2023)
Total Assets -17.21% (FY 2023)

Comprehensive Company Insights

Explore comprehensive insights into Sanofi India Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report

Who are the key members and board of directors at Sanofi India Limited?

Current Directors

Name	Designation	Appointment Date	Status
Deepak Arora	Managing Director	27 Oct 2025	Current
Renee Viswonath Amonkar	Whole-Time Director	26 Sep 2023	Current
Vaibhav Vinayak Karandikar	Director	23 Feb 2021	Current
Rodolfo Hrosz	Director	01 Jun 2022	Current
Rachid Ayari	Whole-Time Director	01 Dec 2023	Current
Usha Thorat	Director	30 Apr 2016	Current

Past Directors

Name	Designation	Cessation	Status
Pramod Abcsdd	Additional Director	27 Oct 2025	Past
Pramod Abcsdd	Director	29 Apr 2016	Past
Pramod Abcsdd	Director Appointed In Casual Vacancy	10 Apr 2015	Past
Pramod Abcsdd	Alternate Director	03 Jul 2008	Past
Pramod Abcsdd	Nodal Officer	04 Sep 2021	Past
Pramod Abcsdd	Whole-Time Director	11 Aug 2025	Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Sanofi India.

Sanofi India Limited, for the financial year ended 2023, experienced modest growth in revenue, with a 2.63% increase. The company also saw a slight decrease in profitability, with a 2.8% decrease in profit. The company's net worth observed a substantial decline by a decrease of 20.4%.

Date	Amount	Transaction Name	Valuation	Lead Investors	Investors
Jul, 2021	Amount	Post-IPO - Grab	Valuation	investors	Emtek
Feb, 2021	Amount	Post-IPO - Grab	Valuation	investors	Signite Partners
Jan, 2021	Amount	Post-IPO - Grab	Valuation	investors	Hana Financial Group , GGV Capital
Feb, 2021	Amount	Post-IPO - Grab	Valuation	investors	Signite Partners

Upgrade Required

Full access to Financial is available only for users with an active Premium plan.

Key Matrics
Balance Sheet
Profit and Loss
Cash Flow
Ratios

Metrics

(FY 2023)

YOY Growth

(FY 2022)

(FY 2021)

(FY 2020)

(FY 2019)

Total Revenue

********

2.63%

*******

Revenue from Operations

*******

2.92%

*******

Total Assets

*******

-17.21%

*******

Profit or Loss

*******

-2.80%

*******

Net Worth

*******

-20.40%

*******

EBITDA

*******

14.14%

*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Sanofi India?

In 2023, Sanofi India had a promoter holding of 60.40% and a public holding of 39.59%. The company had 1 Subsidiary. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)

Promoters: 92.83%
Public: 4.10%
Others: 3.07%

Shareholding Pattern over the Year

	FY (2024)	FY (2023)	FY (2022)	FY (2021)	FY (2020)
Promoters	92.83	94.62	94.55	94.55	94.55
Public	4.10	3.89	3.95	3.96	3.98
Others	3.07	1.49	1.50	1.49	1.47

Upgrade Required

Full access to Ownership and Shareholding Structure is available only for users with an active Premium plan.

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)

Open Charges

₹1,707,215,200.00

Satisfied Charges

₹408,078,000.00

Charges Breakdown by Lending Institutions

State Bank Of India : 111.60 Cr
Icici Limited : 25.00 Cr
Hdfc Limited : 21.75 Cr
The First National City : 3.20 Cr
Unit Trust Of India : 2.00 Cr
Others : 7.17 Cr

Latest Charge Details

Date	Lender	Amount	Status
20 Sep 2001	Hdfc Limited	₹19.75 Cr	Open
25 Oct 1993	Icici Limited	₹5.00 Cr	Open
31 Dec 1992	State Bank Of India	₹40.00 Cr	Open
03 Dec 1992	State Bank Of India	₹40.00 Cr	Open
11 Sep 1992	State Bank Of India	₹3.20 Cr	Open

Explore comprehensive loan charge details -

How Many Employees Work at Sanofi India?

Sanofi India has a workforce of 2191 employees as of Jul 30, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee Date	Number of Employees
2020	78,000
2021	80,500
2022	83,200
2023	86,000
2024	89,500
2025	92,000

Upgrade Required

Full access to People is available only for users with an active Premium plan.

Deals i

Gain comprehensive insights into the Deals and Valuation data of Sanofi India, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Sanofi India's trajectory.

Rating

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Sanofi India

Recent Activity within the Organization

Director Appointment

Progress on Deepak Arora was appointed as a Managing Director was appointed as a Managing Director on 27 Oct 2025 & has been associated with this company since 8 months 11 days . was documented.
27 Oct 2025
Director Appointment

Mahadev Keshav Gawade was appointed as a Whole-time director was appointed as a Whole-time director on 11 Aug 2025 & has been associated with this company since 10 months 27 days . was recorded as a recent event.
11 Aug 2025
Annual General Meeting

Progress on Sanofi India Limited last Annual general meeting of members was held on 15 May 2025 as per latest MCA records. was documented.
15 May 2025
Balance Sheet

Progress on Sanofi India Limited has filed its annual Financial statements for the year ended 31 Dec 2024 with Roc Mumbai. was documented.
31 Dec 2024
Director Appointment

The activity Eric Yves Mansion was appointed as a Director was appointed as a Director on 03 Jun 2024 & has been associated with this company since 2 years 1 month . was completed.
03 Jun 2024
Director Appointment

Progress on Rachid Ayari was appointed as a Cfo was appointed as a Cfo on 12 Jan 2024 & has been associated with this company since 2 years 5 months . was documented.
12 Jan 2024

Explore recent activity and updates - View Recent Activity